Human skin grown in a lab, computer simulations, and new approaches to vaccine quality control. These are just some of the new ideas which experts say could reduce the number of animals used in developing, approving and producing medicines.
What if I told you that these technologies already exist and the trick now is to pull them together, apply them and have them accepted by authorities? Well, it’s true.
It won’t be long now until the annual European Partnership for Alternative Approaches to Animal Testing (EPAA) conference which takes place on 9 November here in Brussels.
The EPAA is an independent platform which brings together the European Commission and industry groups to collaborate on implementing the 3 Rs Declaration. It has been running since 2005 and has done a lot to bring together people who don’t talk as much as they should – like companies and regulators, or scientists and EU officials.